Stock of Interest

Posted On: September 4, 2023

Stock Report: BIOCON(NSE) 01 Sep 2023

Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Generics, Biosimilars, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene.  

#xCalData predicts that # BIOCON will continue its bullish phase over the next five days and trend within the range of 252 to 267. 

In comparison to the previous month, the price of the stock has experienced a increase of 1.95% indicating a bullish.

The Stock has doubled twice since 07 Jan 2015 and took an average of 1.5 years to double.

The stock has not shown seasonality trend in the past. 

Reviewing the returns for the past 5 years for the same week, we see the stock has given negative returns in 2 years in the past. 

Majority of the technical ratios trend towards Bullish side of the spectrum. Only some of the technical indicators namely Trendline indicate Bearish view. 

Collectively, xCalData suggests the stock would be in Bullish zone for next 5 days.

#xCalData is an exceptional app available for Android devices that offers unbiased insights into stocks, allowing investors to make informed decisions. With its user-friendly interface and comprehensive features, xCalData provides a valuable resource for anyone interested in the stock market.  Download the app from google play. 

For Actionable Intelligence, subscribe to xCalData app on Android devices: https://tinyurl.com/downloadxCalData